Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Wallace, Robert G ^a   Twomey, Laura C ^a   Custaud, Marc Antoine ^b   Moyna, Niall ^a   Cummins, Philip M ^a   Mangone, Marco ^c   Murphy, Ronan P ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b UNIVERSITÉ D'ANGERS   (France)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL NUCLEUS DNA; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MITOCHONDRIAL DNA; TUMOR MARKER;

AGING; BLOOD ANALYSIS; BLOOD CELL; BLOOD VESSEL; BODY FLUID; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL COMPOSITION; CHRONIC DISEASE; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DNA METHYLATION; DNA MODIFICATION; EPIGENETIC DRIFT; EPIGENETICS; GENE FUNCTION; HUMAN; INFLAMMATION; LIFESTYLE MODIFICATION; MEMBRANE MICROPARTICLE; MITOCHONDRION; OBESITY; PHYSICAL ACTIVITY; PHYSIOLOGICAL PROCESS; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE; VASCULAR REMODELING; BLOOD; GENETIC EPIGENESIS; GENETICS; PATHOLOGY;

AGING; BIOMARKERS, TUMOR; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; EPIGENESIS, GENETIC; HUMANS; INFLAMMATION; MICRORNAS;

EID: 84958069026     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/2465763     Document Type: Review

References (61)

1. K. J. Hunt, N. L. Baker, P. A. Cleary, R. Klein, G. Virella, and M. F. Lopes-Virella, "Longitudinal association between endothelial dysfunction, inflammation, and clotting biomarkers with subclinical atherosclerosis in type 1 diabetes: an evaluation of the DCCT/EDIC cohort," Diabetes Care, vol. 38, no. 7, pp. 1281-1289, 2015.
2. J. D. Fontes, J. F. Yamamoto, M. G. Larson et al., "Clinical correlates of change in inflammatory biomarkers: the Framingham Heart Study," Atherosclerosis, vol. 228, no. 1, pp. 217-223, 2013.
3. N. Hopkins, G. Stratton, N. D. Ridgers, L. E. F. Graves, N. T. Cable, and D. J. Green, "Lack of relationship between sedentary behaviour and vascular function in children," European Journal of Applied Physiology, vol. 112, no. 2, pp. 617-622, 2012.
4. D. A. Bottino, F. G. Lopes, F. J. de Oliveira, A. D. Mecenas, R. Clapauch, and E. Bouskela, "Relationship between biomarkers of inflammation, oxidative stress and endothelial/microcirculatory function in successful aging versus healthy youth: a transversal study," BMC Geriatrics, vol. 15, article 41, 2015.
5. M. Mohiuddin, H.-A. Pan, Y.-C. Hung, and G. S. Huang, "Control of growth and inflammatory response of macrophages and foam cells with nanotopography," Nanoscale Research Letters, vol. 7, no. 1, article 394, 2012.
6. J. Lugrin, N. Rosenblatt-Velin, R. Parapanov, and L. Liaudet, "The role of oxidative stress during inflammatory processes," Biological Chemistry, vol. 395, no. 2, pp. 203-230, 2014.
7. R. C. Marchiori, L. A. F. Pereira, A. A. Naujorks et al., "Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment," BMC Endocrine Disorders, vol. 15, article 32, 2015.
8. R. Casas, E. Sacanella, M. Urpí-Sardà et al., "The effects of the Mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial," PLoS ONE, vol. 9, no. 6, Article ID e100084, 2014.
9. E. White, "Measurement error in biomarkers: sources, assessment, and impact on studies," IARC Scientific Publications, no. 163, pp. 143-161, 2011.
10. D. J. West, M. D. Campbell, J. T. Gonzalez et al., "The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study," Cardiovascular Diabetology, vol. 14, article 71, 2015.
11. D. Baumeister, R. Akhtar, S. Ciufolini, C. M. Pariante, and V. Mondelli, "Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α," Molecular Psychiatry, 2015.
12. H. Cung, M. J. Aragon, K. Zychowski et al., "Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients," Journal of Translational Medicine, vol. 13, no. 1, article 99, 2015.
13. A. F. Carlin, P. Aristizabal, Q. Song et al., "Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection," Hepatology, vol. 62, no. 4, pp. 1047-1058, 2015.
14. M. Bawadekar, M. De Andrea, I. Lo Cigno et al., "The extracellular IFI16 protein propagates inflammation in endothelial cells via p38 MAPK and NF-eκB p65 activation," Journal of Interferon &Cytokine Research, vol. 35, no. 6, pp. 441-453, 2015.
15. A. Alabdali, L. Al-Ayadhi, and A. El-Ansary, "Association of social and cognitive impairment and biomarkers in autism spectrum disorders," Journal of Neuroinflammation, vol. 11, article 4, 2014.
16. P. Brindle, A. Beswick, T. Fahey, and S. Ebrahim, "Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review," Heart, vol. 92, no. 12, pp. 1752-1759, 2006.
17. J. A. Hernesniemi, I. Seppälä, L.-P. Lyytikäinen et al., "Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey - a meta-analysis of three independent studies," PLoS ONE, vol. 7, no. 1, Article ID e28931, 2012.
18. S. L. Berger, T. Kouzarides, R. Shiekhattar, and A. Shilatifard, "An operational definition of epigenetics," Genes and Development, vol. 23, no. 7, pp. 781-783, 2009.
19. G. Riddihough and L. M. Zahn, "What is epigenetics?" Science, vol. 330, no. 6004, p. 611, 2010.
20. S. Udali, P. Guarini, S. Moruzzi, S.-W. Choi, and S. Friso, "Cardiovascular epigenetics: from DNA methylation to microR-NAs," Molecular Aspects of Medicine, vol. 34, no. 4, pp. 883-901, 2013.
21. P. A. Jones, "Functions of DNA methylation: islands, start sites, gene bodies and beyond," Nature Reviews Genetics, vol. 13, no. 7, pp. 484-492, 2012.
22. P. A. Jones, "The DNA methylation paradox," Trends in Genetics, vol. 15, no. 1, pp. 34-37, 1999.
23. T. Yuan, Y. Jiao, S. de Jong et al., "An integrative multi-scale analysis of the dynamic DNA methylation landscape in aging," PLoS Genetics, vol. 11, no. 2, Article ID e1004996, 2015.
24. K. Day, L. L. Waite, A. Thalacker-Mercer et al., "Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape," Genome Biology, vol. 14, no. 9, article R102, 2013.
25. P. Valencia-Morales Mdel, S. Zaina, H. Heyn et al., "The DNA methylation drift of the atherosclerotic aorta increases with lesion progression," BMC Medical Genomics, vol. 8, article 7, 2015.
26. R. E. Marioni, S. Shah, A. F. McRae et al., "DNA methylation age of blood predicts all-cause mortality in later life," Genome Biology, vol. 16, article 25, 2015.
27. N. T. Jenkins, J. S. Martin, M. H. Laughlin, and J. Padilla, "Exercise-induced signals for vascular endothelial adaptations: implications for cardiovascular disease," Current Cardiovascular Risk Reports, vol. 6, no. 4, pp. 331-346, 2012.
28. S. Mora, N. Cook, J. E. Buring, P. M. Ridker, and I.-M. Lee, "Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms," Circulation, vol. 116, no. 19, pp. 2110-2118, 2007.
29. B. Egan, P. L. O'Connor, J. R. Zierath, and D. J. O'Gorman, "Time course analysis reveals gene-specific transcript and protein kinetics of adaptation to short-term aerobic exercise training in human skeletal muscle," PLoS ONE, vol. 8, no. 9, Article ID e74098, 2013.
30. T. Rönn, P. Volkov, C. Davegårdh et al., "A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue," PLoS Genetics, vol. 9, no. 6, Article ID e1003572, 2013.
31. S. Horvath, W. Erhart, M. Brosch et al., "Obesity accelerates epigenetic aging of human liver," Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 43, pp. 15538-15543, 2014.
32. T. Rönn, P. Volkov, L. Gillberg et al., "Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood," Human Molecular Genetics, vol. 24, no. 13, pp. 3792-3813, 2015.
33. L. Gabel, N. D. Ridgers, P. A. Della Gatta et al., "Associations of sedentary time patterns and TV viewing time with inflammatory and endothelial function biomarkers in children," Pediatric Obesity, 2015.
34. V. Friand, G. David, and P. Zimmermann, "Syntenin and syndecan in the biogenesis of exosomes," Biology of the Cell, vol. 107, no. 10, pp. 331-341, 2015.
35. M. Simons and G. Raposo, "Exosomes - vesicular carriers for intercellular communication," Current Opinion in Cell Biology, vol. 21, no. 4, pp. 575-581, 2009.
36. D. Burger, S. Schock, C. S. Thompson, A. C. Montezano, A. M. Hakim, and R. M. Touyz, "Microparticles: biomarkers and beyond," Clinical Science, vol. 124, no. 7, pp. 423-441, 2013.
37. Y. Ren, J. Yang, R. Xie et al., "Exosomal-like vesicles with immune-modulatory features are present in human plasma and can induce CD4+ T-cell apoptosis in vitro," Transfusion, vol. 51, no. 5, pp. 1002-1011, 2011.
38. T. Takahashi, S. Kobayashi, N. Fujino et al., "Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro," Experimental Lung Research, vol. 39, no. 4-5, pp. 155-161, 2013.
39. C. Jung, P. Sörensson, N. Saleh, H. Arheden, L. Rydén, and J. Pernow, "Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction," Atherosclerosis, vol. 221, no. 1, pp. 226-231, 2012.
40. J. Garnacho-Montero, M. J. Huici-Moreno, A. Gutiérrez-Pizarraya et al., "Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis," Critical Care, vol. 18, no. 3, article R116, 2014.
41. A. Zomer, T. Vendrig, E. S. Hopmans, M. van Eijndhoven, J. M. Middeldorp, and D. M. Pegtel, "Exosomes: fit to deliver small RNA," Communicative & Integrative Biology, vol. 3, no. 5, pp. 447-450, 2010.
42. P. K. Juvvuna, P. Khandelia, L. M. Lee, and E. V. Makeyev, "Argonaute identity defines the length of mature mammalian microRNAs," Nucleic Acids Research, vol. 40, no. 14, pp. 6808-6820, 2012.
43. M. S. Jamaluddin, S. M. Weakley, L. Zhang et al., "miRNAs: roles and clinical applications in vascular disease," Expert Review of Molecular Diagnostics, vol. 11, no. 1, pp. 79-89, 2011.
44. M. S. Ebert and P. A. Sharp, "Roles for microRNAs in conferring robustness to biological processes," Cell, vol. 149, no. 3, pp. 515-524, 2012.
45. J. Zhu, T. Chen, L. Yang et al., "Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10," PLoS ONE, vol. 7, no. 11, Article ID e46551, 2012.
46. L. M. Simon, L. C. Edelstein, S. Nagalla et al., "Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics, " Blood, vol. 123, no. 16, pp. e37-e45, 2014.
47. P. Willeit, A. Zampetaki, K. Dudek et al., "Circulating microR-NAs as novel biomarkers for platelet activation," Circulation Research, vol. 112, no. 4, pp. 595-600, 2013.
48. P. Ferroni, S. Riondino, N. Vazzana, N. Santoro, F. Guadagni, and G. Davì, "Biomarkers of platelet activation in acute coronary syndromes," Thrombosis and Haemostasis, vol. 108, no. 6, pp. 1109-1123, 2012.
49. P. Landry, I. Plante, D. L. Ouellet, M. P. Perron, G. Rousseau, and P. Provost, "Existence of a microRNA pathway in anucleate platelets," Nature Structural & Molecular Biology, vol. 16, no. 9, pp. 961-966, 2009.
50. B. Laffont, A. Corduan, H. Plé et al., "Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles," Blood, vol. 122, no. 2, pp. 253-261, 2013.
51. O. Gidlöf,M.van der Brug, J. Ohman et al., "Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression," Blood, vol. 121, no. 19, pp. 3908-3917, 2013.
52. Y. Pan, H. Liang, H. Liu et al., "Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor," Journal of Immunology, vol. 192, no. 1, pp. 437-446, 2014.
53. D. D. McManus and J. E. Freedman, "MicroRNAs in platelet function and cardiovascular disease," Nature Reviews Cardiology, vol. 12, no. 12, pp. 711-717, 2015.
54. J. A. Ward, N. Esa, R. Pidikiti et al., "Circulating cell and plasma microRNA profiles differ between Non-ST-segment and STsegment-elevation myocardial infarction," Family Medicine & Medical Science Research, vol. 2, no. 2, article 108, 2013.
55. A. Kumar and C. P. Cannon, "Acute coronary syndromes: diagnosis and management, part I," Mayo Clinic Proceedings, vol. 84, no. 10, pp. 917-938, 2009.
56. B. M. Sondermeijer, A. Bakker, A. Halliani et al., "Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340∗ and miRNA624∗," PLoS ONE, vol. 6, no. 10, Article ID e25946, 2011.
57. P. A. Kramer, S. Ravi, B. Chacko, M. S. Johnson, and V. M. Darley-Usmar, "A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers," Redox Biology, vol. 2, no. 1, pp. 206-210, 2014.
58. P. M. Antony, O. Boyd, C. Trefois et al., "Platelet mitochondrial membrane potential in Parkinson's disease," Annals of Clinical and Translational Neurology, vol. 2, no. 1, pp. 67-73, 2015.
59. S. Zharikov and S. Shiva, "Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease," Biochemical Society Transactions, vol. 41, no. 1, pp. 118-123, 2013.
60. S. M. Jobe, K. M. Wilson, L. Leo et al., "Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis," Blood, vol. 111, no. 3, pp. 1257-1265, 2008.
61. A. A. Baccarelli and H.-M. Byun, "Platelet mitochondrial DNA methylation: a potential new marker of cardiovascular disease," Clinical Epigenetics, vol. 7, no. 1, article 44, 2015.